Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-14-002681)

Filing Details

Accession Number:: 0001493152-14-002681
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-21 13:41:34
Reporting Period:: 2014-08-12

Filing Date:: 2014-08-21
Accepted Time:: 2014-08-21 13:41:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1420030	Targeted Medical Pharma Inc.	TRGM	Pharmaceutical Preparations (2834)	205863618

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1617554	Trust Exemption Charuvastra Elizabeth	C/O Targeted Medical Pharma, Inc. 2980 Beverly Glen Circle, Suite 301 Los Angeles CA 90077	Ceo & Chief Scientific Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-08-12	101,035	$0.40	295,473	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Trust

Footnotes

Cormmon stock held by Elizabeth Charuvastra Exemption Trust. William E. Shell, Trustee, is filing on behalf of the Elizabeth Charuvastra Exemption Trust and disclaims any and all pecuniary interest in the Elizabeth Charuvastra Exemption Trust.